Cantor Fitzgerald reiterates Tesla stock Overweight on strong quarter By Investing.com

Tesla reported a first-quarter beat on revenue, gross margin, and earnings, with free cash flow of $1.444 billion versus consensus expectations of negative $1.78 billion. Cantor Fitzgerald reiterated an Overweight rating and $510 price target, while Tesla raised fiscal 2026 capex guidance to more than $25 billion from $20 billion and expects negative free cash flow for the rest of the year. The company also said Cybercab, Tesla Semi, and Megapack 3 remain on track for volume production this year.

Analysis

The key read-through is not the modest earnings beat; it is the step-up in capex while management is still signaling negative free cash flow. That shifts TSLA from a near-term cash compounding story into a longer-duration reinvestment story, which tends to compress multiple support unless the market believes each incremental dollar of capex has a credible, near-term payback. In other words, the stock now needs evidence of unit growth or software/service monetization to justify funding intensity, not just margin resilience.

This is a relative winner/loser setup: suppliers tied to factory buildout, power electronics, batteries, and industrial automation should see demand spillover in the next 2-4 quarters, while auto peers face a tougher comparison if Tesla uses the new capacity to defend pricing or accelerate launches. The bigger second-order effect is on sentiment across the EV complex: TSLA can remain resilient even as peers with weaker balance sheets get de-rated, because Tesla is effectively buying option value on future platforms while others are forced into survival mode. That makes TSLA less of a pure auto trade and more of a financing-capable industrial platform trade.

The contrarian risk is that the market may be underestimating capex discipline problems and overestimating timing certainty on new products. If volume production slips even one quarter, the negative FCF window extends into 2027, and investors will start discounting a more expensive, slower-return asset base. Conversely, if production ramps on schedule, the stock can re-rate quickly because the current skepticism around fair value leaves room for a sharp multiple expansion on any evidence that capex is converting into deliverable volume rather than optionality.

For the next 1-3 months, this is likely a headline-driven stock with asymmetric reaction to execution updates rather than macro. The setup is bullish, but only if the market believes the company can monetize the new spending through unit growth faster than depreciation and working-capital drag build up. Absent that proof, rallies are likely to fade into strength as investors wait for a better entry point closer to the next production milestone.

Key Decisions for Investors

• Stay tactically long TSLA only into execution catalysts over the next 4-8 weeks; use a smaller size than usual because the capex reset raises the probability of post-rally digestion. Risk/reward favors buying dips on production confirmation, not chasing strength.
• Express a relative-value long TSLA / short a weaker EV OEM or EV supplier basket over 1-3 months; Tesla’s balance sheet and funding flexibility make it the only name that can convert capex into optionality without immediate solvency pressure.
• Buy TSLA call spreads 3-6 months out rather than outright calls; the stock has upside if volume ramps, but the negative FCF narrative caps near-term multiple expansion. Structure for a controlled premium outlay with defined upside if milestones hit.
• If TSLA rallies into analyst-target optimism, trim into strength and wait for evidence of capex payback in deliveries or margin expansion. The market will likely give back gains if the next update emphasizes spending rather than throughput.
• Watch suppliers exposed to Tesla buildout and product ramp for delayed upside over the next 2-4 quarters; they may offer better risk/reward than TSLA if the market wants cleaner operating leverage without the headline volatility.